Form 4: West Pharmaceutical Services Director Acquires Shares

Director William F. Feehery acquired 564 shares of West Pharmaceutical Services Inc. common stock on April 23, 2024.

Summary

• On April 23, 2024, William F. Feehery, a director of West Pharmaceutical Services Inc., acquired 564 shares of common stock.
• The acquisition was made at a price of $0 per share.
• Following the transaction, Feehery directly owns 30,292.13 shares of West Pharmaceutical Services Inc.
• The acquired shares are restricted stock units that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, indicating a routine transaction. It doesn't convey any strong positive or negative sentiment.

Future Outlook

The restricted stock units will vest in full on the date of the next annual shareholder meeting.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence due to the director's increased investment in the company.

Key Dates